HI
DNA icon

Harbour Investments’s Ginkgo Bioworks DNA Stock Holding History

Harbour Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$347 Buy
56
+17
+44% +$141 ﹤0.01% 4323
2025
Q4 		$324 Hold
39
– – ﹤0.01% 3613
2025
Q3 		$569 Buy
39
+19
+95% +$227 ﹤0.01% 3493
2025
Q2 		$225 Hold
20
– – ﹤0.01% 3462
2025
Q1 		$114 Hold
20
– – ﹤0.01% 3466
2024
Q4 		$196 Hold
20
– – ﹤0.01% 3369
2024
Q3 		$163 Hold
20
– – ﹤0.01% 3287
2024
Q2 		$267 Buy
20
+12
+150% +$358 ﹤0.01% 3148
2024
Q1 		$348 Buy
+8
New +$414 ﹤0.01% 3067
2022
Q4 		– Sell
-28
Closed -$3K – 3021
2022
Q3 		$3K Hold
28
– – ﹤0.01% 2302
2022
Q2 		$3K Buy
+28
New +$3.42K ﹤0.01% 2302
2021
Q4 		$4K Sell
13
-168
-93% -$79.8K ﹤0.01% 2221
2021
Q3 		$84K Buy
+181
New +$88.1K ﹤0.01% 1477

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return